Welcome to LookChem.com Sign In|Join Free

Product Name

  • or
Home > Products > 

Mabuterol hydrochloride
Basic Information Post buying leads Suppliers Cas Database
Basic InformationSuppliers
  • Name Mabuterol hydrochloride
  • EINECS1312995-182-4
  • CAS No. 56341-08-3
  • Density1.278 g/cm3
  • PSA58.28000
  • LogP4.33460
  • SolubilityN/A
  • Melting Point85-87oC
  • FormulaC13H18ClF3N2O
  • Boiling Point375.9 °C at 760 mmHg
  • Molecular Weight310.747
  • Flash Point181.1 °C
  • Transport InformationN/A
  • AppearanceN/A
  • Safety
  • Risk CodesN/A
  • Molecular Structure
    Molecular Structure of 56341-08-3 (MABUTEROL)
  • Hazard SymbolsN/A
  • SynonymsN/A
  • Article Data3

Mabuterol hydrochloride Chemical Properties

Product Name: KF-868 (CAS NO.54240-36-7)


Molecular Formula: C13H18ClF3N2O.HCl
Molecular Weight: 347.2g/mol
Mol File: 54240-36-7.mol
Appearance: A solid
Boiling point: 375.9°Cat760mmHg
Flash Point: 181.1 °C
Enthalpy of Vaporization: 65.77 kJ/mol
Vapour Pressure: 2.57E-06 mmHg at 25°C
H-Bond Donor: 4
H-Bond Acceptor: 6

Mabuterol hydrochloride Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 intravenous 27500ug/kg (27.5mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
dog LD50 oral 229mg/kg (229mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
human TDLo oral 1143ng/kg (0.001143mg/kg) BEHAVIORAL: TREMOR

BEHAVIORAL: HEADACHE		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1697, 1984.
human TDLo oral 60ug/kg/6W (0.06mg/kg) BEHAVIORAL: TREMOR

CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1699, 1984.
mouse LD50 intraperitoneal 60mg/kg (60mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
mouse LD50 intravenous 36500ug/kg (36.5mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 652, 1984.
mouse LD50 oral 200mg/kg (200mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
mouse LD50 subcutaneous 113mg/kg (113mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
rabbit LD50 intravenous 18300ug/kg (18.3mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
rabbit LD50 oral 243mg/kg (243mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
rat LD50 intraperitoneal 76300ug/kg (76.3mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
rat LD50 intravenous 26400ug/kg (26.4mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
rat LD50 oral 306mg/kg (306mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.
rat LD50 subcutaneous 117mg/kg (117mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

LUNGS, THORAX, OR RESPIRATION: DYSPNEA		 Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 1680, 1984.

Mabuterol hydrochloride Safety Profile

Poison by intravenous route. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of F−, NOx, and HCl.

Mabuterol hydrochloride Specification

 KF-868 ,its CAS NO. is 54240-36-7,the synonyms is Mabuterolhcl ; Benzenemethanol, 4-amino-3-chloro-a-[[(1,1-dimethylethyl)amino]methyl]-5-(trifluoromethyl)-, monohydrochloride (9ci) ; Broncholin ; Dl-mabuterol hydrochloride ; KF868 (pharmaceutical) .

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 56341-08-3
Related Products

Hot Products

Post a RFQ